Common Equity: The sum of all common equity items.
Pasithea Therapeutics Corp. (KTTA) had Common Equity of $54.81M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.87M |
|
-- |
|
-- |
|
$4.88M |
|
$-4.88M |
|
$2.01M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-4.88M |
|
$-4.72M |
|
24.34M |
|
24.34M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$52.73M |
|
-- |
|
$3.62M |
|
$56.35M |
|
$1.49M |
|
-- |
|
$0.05M |
|
$1.54M |
|
|
Common Equity |
$54.81M |
$51.19M |
|
$54.81M |
|
24.94M |
|
| Cash Flow Statement Financials | |
$-4.79M |
|
-- |
|
$0.00M |
|
$55.26M |
|
$50.50M |
|
$-4.76M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
35.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.24% |
|
-5.61% |
|
-5.09% |
|
-5.24% |
|
$2.20 |
|
$-0.20 |
|
$-0.20 |
|